Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.52B | 14.19B | 14.27B | 14.00B | 15.48B | 35.71B |
Gross Profit | 6.26B | 6.17B | 6.70B | 6.28B | 6.95B | 8.16B |
EBITDA | -938.68M | -57.72M | 1.89B | 1.02B | 539.39M | 2.13B |
Net Income | -666.76M | -530.40M | 1.01B | 254.88M | 310.44M | 1.43B |
Balance Sheet | ||||||
Total Assets | 31.03B | 29.53B | 27.08B | 25.41B | 25.09B | 27.07B |
Cash, Cash Equivalents and Short-Term Investments | 10.59B | 10.10B | 12.86B | 14.31B | 13.77B | 17.97B |
Total Debt | 14.92B | 17.11B | 11.66B | 9.47B | 10.26B | 11.55B |
Total Liabilities | 21.27B | 20.20B | 16.28B | 15.44B | 15.44B | 17.33B |
Stockholders Equity | 9.62B | 9.20B | 10.66B | 9.80B | 9.39B | 9.21B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.20B | -424.17M | 1.56B | 38.14M | 2.31B |
Operating Cash Flow | 0.00 | -1.14B | -385.00M | 1.59B | 683.15M | 2.43B |
Investing Cash Flow | 0.00 | -6.59B | -1.64B | -708.65M | -1.28B | 72.71M |
Financing Cash Flow | 0.00 | 4.63B | 572.01M | -345.60M | -692.96M | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥6.39B | 22.71 | ― | 29.19% | ― | ||
72 Outperform | ¥6.24B | 53.61 | ― | 14.82% | 191.31% | ||
69 Neutral | ¥6.65B | 39.92 | ― | 13.76% | -15.36% | ||
63 Neutral | $33.76B | 6.14 | -11.84% | 1.84% | 5.29% | -18.23% | |
58 Neutral | ¥4.72B | 49.27 | ― | 51.83% | -62.04% | ||
53 Neutral | ¥7.21B | ― | 3.89% | -15.71% | 65.07% | ||
47 Neutral | ¥6.71B | ― | ― | -0.55% | -158.87% |